Literature DB >> 7961722

A1 adenosine receptors. Two amino acids are responsible for species differences in ligand recognition.

A L Tucker1, A S Robeva, H E Taylor, D Holeton, M Bockner, K R Lynch, J Linden.   

Abstract

Species differences in ligand binding to A1 adenosine receptors were localized to the seventh transmembrane (TM7) region based on the binding of [8-3H]cyclopentyl-1, 3-dipropylxanthine and three other ligands to wild type and six bovine/canine interspecies receptor chimeras expressed in COS-1 cells. Subsequent site-directed mutagenesis experiments identified amino acid 270 (isoleucine/methionine, bovine/canine) as being primarily responsible for species differences in the binding of N6-adenine-substituted compounds, R-N6-phenylisopropyladenosine (R-PIA) and (S)-N6-endonorbornan-2-yl-9-methyladenine, and the C-8-substituted xanthine, [3H]cyclopentyl-1,3-dipropylxanthine. These data are consistent with the hypothesis that the N6 region of adenines and the C-8-region of xanthines bind to the same region of the receptor. A second TM7 amino acid, 277 (serine/threonine, bovine/canine), selectively influences the binding of the ribose-substituted adenosine analog, 5'-N-ethylcarboxamidoadenosine to a variable extent, depending on the nature of amino acid 270. We hypothesize that amino acid 270 of the A1 receptor interacts with the N6 region of adenosine, while amino acid 277 is important, especially in the absence of an N6 substitution, for interactions with a distinct nucleoside region, possibly on the ribose.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7961722

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Dominance of G(s) in doubly G(s)/G(i)-coupled chimaeric A(1)/A(2A) adenosine receptors in HEK-293 cells.

Authors:  A L Tucker; L G Jia; D Holeton; A J Taylor; J Linden
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

2.  Identification by site-directed mutagenesis of residues involved in ligand recognition and activation of the human A3 adenosine receptor.

Authors:  Zhan-Guo Gao; Aishe Chen; Dov Barak; Soo-Kyung Kim; Christa E Müller; Kenneth A Jacobson
Journal:  J Biol Chem       Date:  2002-03-12       Impact factor: 5.157

3.  Mutagenesis reveals structure-activity parallels between human A2A adenosine receptors and biogenic amine G protein-coupled receptors.

Authors:  Q Jiang; B X Lee; M Glashofer; A M van Rhee; K A Jacobson
Journal:  J Med Chem       Date:  1997-08-01       Impact factor: 7.446

4.  Purine receptors: GPCR structure and agonist design.

Authors:  Kenneth A Jacobson; Soo-Kyung Kim; Stefano Costanzi; Zhan-Guo Gao
Journal:  Mol Interv       Date:  2004-12

Review 5.  Adenosine receptors and angiogenesis.

Authors:  John A Auchampach
Journal:  Circ Res       Date:  2007-11-26       Impact factor: 17.367

6.  Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition.

Authors:  Q Jiang; A M Van Rhee; J Kim; S Yehle; J Wess; K A Jacobson
Journal:  Mol Pharmacol       Date:  1996-09       Impact factor: 4.436

7.  Molecular Architecture of G Protein-Coupled Receptors.

Authors:  A Michiel van Rhee; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1996-01-01       Impact factor: 4.360

8.  Effect of exogenous adenosine and monensin on glycolytic flux in isolated perfused normoxic rat hearts: role of pyruvate kinase.

Authors:  S Peltier; Y Burelle; V Novel-Chate; L Demaison; M Verdys; V Saks; C Keriel; X M Leverve
Journal:  Mol Cell Biochem       Date:  2005-09       Impact factor: 3.396

9.  Characterization of the A2B adenosine receptor from mouse, rabbit, and dog.

Authors:  John A Auchampach; Laura M Kreckler; Tina C Wan; Jason E Maas; Dharini van der Hoeven; Elizabeth Gizewski; Jayashree Narayanan; Garren E Maas
Journal:  J Pharmacol Exp Ther       Date:  2009-01-13       Impact factor: 4.030

10.  Phe369(7.38) at human 5-HT(7) receptors confers interspecies selectivity to antagonists and partial agonists.

Authors:  Thibault Varin; Hugo Gutiérrez-de-Terán; Marián Castro; José Brea; Frederic Fabis; François Dauphin; Johan Aqvist; Alban Lepailleur; Pilar Perez; Javier Burgueño; José Miguel Vela; Maria Isabel Loza; Jordi Rodrigo
Journal:  Br J Pharmacol       Date:  2009-11-18       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.